Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

Clinical trial NCT03678753 · COMPLETED

Trial details

NCT number: NCT03678753
Sponsor: SK Life Science, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Generalized Epilepsy

Start date: 2018-10-03
Primary completion: 2025-05-26
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.